These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26646841)

  • 1. Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.
    Ulusoy C; Zibandeh N; Yıldırım S; Trakas N; Zisimopoulou P; Küçükerden M; Tașlı H; Tzartos S; Göker K; Tüzün E; Akkoç T
    J Neuroinflammation; 2015 Dec; 12():231. PubMed ID: 26646841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis.
    Yilmaz V; Ulusoy C; Hajtovic S; Turkoglu R; Kurtuncu M; Tzartos J; Lazaridis K; Tuzun E
    Immunol Invest; 2021 Aug; 50(6):671-684. PubMed ID: 32597289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK.
    Küçükerden M; Huda R; Tüzün E; Yılmaz A; Skriapa L; Trakas N; Strait RT; Finkelman FD; Kabadayı S; Zisimopoulou P; Tzartos S; Christadoss P
    J Neuroimmunol; 2016 Jun; 295-296():84-92. PubMed ID: 27235354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice.
    Ulusoy C; Kim E; Tüzün E; Huda R; Yılmaz V; Poulas K; Trakas N; Skriapa L; Niarchos A; Strait RT; Finkelman FD; Turan S; Zisimopoulou P; Tzartos S; Saruhan-Direskeneli G; Christadoss P
    Clin Immunol; 2014 Apr; 151(2):155-63. PubMed ID: 24589747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice.
    Koral G; Ulusoy C; Cossins J; Lazaridis K; Türkoğlu R; Dong YY; Tüzün E; Yılmaz V
    J Neuroimmunol; 2023 Oct; 383():578195. PubMed ID: 37660538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
    Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis.
    Mori S; Kubo S; Akiyoshi T; Yamada S; Miyazaki T; Hotta H; Desaki J; Kishi M; Konishi T; Nishino Y; Miyazawa A; Maruyama N; Shigemoto K
    Am J Pathol; 2012 Feb; 180(2):798-810. PubMed ID: 22142810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK).
    Jha S; Xu K; Maruta T; Oshima M; Mosier DR; Atassi MZ; Hoch W
    J Neuroimmunol; 2006 Jun; 175(1-2):107-17. PubMed ID: 16697051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
    Maruyama N; Shigemoto K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis.
    Lazaridis K; Baltatzidou V; Tektonidis N; Tzartos SJ
    J Neuroimmunol; 2020 Feb; 339():577136. PubMed ID: 31855721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
    Oshima M; Iida-Klein A; Maruta T; Deitiker PR; Atassi MZ
    Autoimmunity; 2017 Sep; 50(6):346-353. PubMed ID: 28850269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance.
    Reuveni D; Aricha R; Souroujon MC; Fuchs S
    Front Immunol; 2020; 11():403. PubMed ID: 32256489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of myasthenia by immunization against muscle-specific kinase.
    Shigemoto K; Kubo S; Maruyama N; Hato N; Yamada H; Jie C; Kobayashi N; Mominoki K; Abe Y; Ueda N; Matsuda S
    J Clin Invest; 2006 Apr; 116(4):1016-24. PubMed ID: 16557298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.